Omega-3 fatty acids in ADHD and related neurodevelopmental disorders

References

• Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. Journal of Abnormal Child Psychology 1987; 15: 75–90
   PubMed Web of Science ®Google Scholar
• Arnold LE. Sex differences in ADHD: Conference summary. Journal of Abnormal Child Psychology 1996; 24: 555–569
   PubMed Web of Science ®Google Scholar
• Arnold LE. Alternative treatments for adults with attention-deficit hyperactivity disorder (ADHD). Annals of the New York Academy of Sciences 2001; 931: 310–341
   PubMed Web of Science ®Google Scholar
• Arnold LE, DiSilvestro RA. Zinc in attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2005; 15: 619–627
   PubMed Web of Science ®Google Scholar
• Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K. Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biological Psychiatry 1989; 25: 222–228
   PubMed Web of Science ®Google Scholar
• Ashwood P, Van de Water J. Is autism an autoimmune disease%. Autoimmunity Reviews 2004; 3: 557–562
   PubMedGoogle Scholar
• Baker SM. A biochemical approach to the problem of dyslexia. Journal of Learning Disabilities 1985; 18(10)581–584
   PubMedGoogle Scholar
• Bekaroglu M, Aslan Y, Gedik Y, Deger O, Mocan H, Erduran E, et al. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: A research note. Journal of Child Psychology and Psychiatry 1996; 37: 225–227
   PubMed Web of Science ®Google Scholar
• Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukotrienes & Essential Fatty Acids 2004a; 71: 201–204
   PubMed Web of Science ®Google Scholar
• Bell JG, Ross MA, Cyhlarova E, Shrier A, Dick JR, Henderson RJ, et al. Membrane fatty acids, reading and spelling in dyslexic and non-dyslexic adults. BrightonUK 2004b, ISSFAL 6th International Congress, 2004
   Google Scholar
• Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: A characteristic abnormality in neurodevelopmental disorders%. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63: 21–25
   PubMedGoogle Scholar
• Bennett CN, Horrobin DF. Gene targets related to phospholipid and fatty acid metabolism in schizophrenia and other psychiatric disorders: An update. Prostaglandins Leukotrienes & Essential Fatty Acids 2000; 63: 47–59
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone S, Mick E, Wozniak J, Chen L, Ouellette C, et al. Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity%. Journal of the American Academy of Child and Adolescent Psychiatry 1996; 35: 997–1008
   PubMed Web of Science ®Google Scholar
• Bourre JM. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. Journal of Nutrition, Health and Aging 2004; 8: 163–174
   PubMedGoogle Scholar
• Bourre JM, Durand G, Pascal G, Youyou A. Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat. Journal of Nutrition 1989; 119: 15–22
   PubMed Web of Science ®Google Scholar
• Brunner J, Parhofer KG, Schwandt P, Bronisch T. Cholesterol, essential fatty acids, and suicide. Pharmacopsychiatry 2002; 35: 1–5
   PubMed Web of Science ®Google Scholar
• Buitelaar JK, Van-der-Gaag RJ, Swaab-Barneveld H, Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34(8)1025–1032
   PubMed Web of Science ®Google Scholar
• Burd L, Klug MG, Coumbe MJ, Kerbeshian J. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care. Journal of Child Neurology 2003; 18: 555–561
   PubMed Web of Science ®Google Scholar
• Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. British Journal of Nutrition 2002; 88: 411–420
   PubMed Web of Science ®Google Scholar
• Burdge GC, Jones AE, Wootton SA. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. British Journal of Nutrition 2002; 88: 355–363
   PubMed Web of Science ®Google Scholar
• Burgess JR, Stevens LJ. Essential fatty acids in relation to attention deficit hyperactivity disorder. Phospholipid spectrum disorders in psychiatry and neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003; 511–519
   Google Scholar
• Burgess JR, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 2000; 71: 327S–330S
   PubMed Web of Science ®Google Scholar
• Calder PC. N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic. Lipids 2003; 38: 343–352
   PubMed Web of Science ®Google Scholar
• Carlson SE, Neuringer M. Polyunsaturated fatty acid status and neurodevelopment: A summary and critical analysis of the literature. Lipids 1999; 34: 171–178
   PubMed Web of Science ®Google Scholar
• Chen C, Bazan NG. Lipid signaling: Sleep, synaptic plasticity, and neuroprotection. Prostaglandins and other Lipid Mediators 2005; 77: 65–76
   PubMed Web of Science ®Google Scholar
• Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang SC. Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan. Journal of Nutritional Biochemistry 2004; 15: 467–472
   PubMed Web of Science ®Google Scholar
• Colquhoun I, Bunday S. A lack of essential fatty acids as a possible cause of hyperactivity in children. Medical Hypotheses 1981; 7: 673–679
   PubMed Web of Science ®Google Scholar
• Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology 1999; 14: 388–394
   PubMed Web of Science ®Google Scholar
• Conners CK. Conners’ Parent Rating Scales—Revised. Multi-Health Systems Inc, New York 1997
   Google Scholar
• Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 2003; 60: 837–844
   PubMed Web of Science ®Google Scholar
• Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, et al. Maternal neuronal antibodies associated with autism and a language disorder. Annals of Neurology 2003; 53: 533–537
   PubMedGoogle Scholar
• Das UN. Essential fatty acids as possible enhancers of the beneficial actions of probiotics. Nutrition 2002; 18: 786
   PubMed Web of Science ®Google Scholar
• Dery M, Toupin J, Pauze R, Verlaan P. Frequency of mental health disorders in a sample of elementary school students receiving special educational services for behavioural difficulties. Canadian Journal of Psychiatry 2004; 49: 769–775
   PubMedGoogle Scholar
• Dilsaver SC, Henderson Fuller S, Akiskal HS. Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention-deficit/hyperactivity disorder in a community mental health clinic. Journal of Clinical Psychiatry 2003; 64: 1170–1176
   PubMed Web of Science ®Google Scholar
• Doyle AE, Faraone SV, DuPre EP, Biederman J. Separating attention deficit hyperactivity disorder and learning disabilities in girls: A familial risk analysis. American Journal of Psychiatry 2001; 158: 1666–1672
   PubMed Web of Science ®Google Scholar
• DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: Interaction with internalizing symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 1994; 33: 894–903
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton R, Tsuang MT. Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): Gender, psychiatric comorbidity, and maternal ADHD. Journal of Abnormal Psychology 1995; 104: 334–345
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Jetton JG, Tsuang MT. Attention deficit disorder and conduct disorder: Longitudinal evidence for a familial subtype. Psychological Medicine 1997; 27: 291–300
   PubMed Web of Science ®Google Scholar
• FDA U. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease. 2000, U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements, October 31, 2000
   Google Scholar
• Fenton WS, Dickerson F, Boronow J, Hibbeln JR, Knable M. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. American Journal of Psychiatry 2001; 158: 2071–2074
   PubMed Web of Science ®Google Scholar
• Fisher SE, DeFries JC. Developmental dyslexia: Genetic dissection of a complex cognitive trait. Nature Reviews Neuroscience 2002; 3: 767–780
   PubMed Web of Science ®Google Scholar
• Gesch CB, Hammond SM, Hampson SE, Eves A, Crowder MJ. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial. British Journal of Psychiatry 2002; 181: 22–28
   PubMed Web of Science ®Google Scholar
• Giltay EJ, Gooren LJ, Toorians AW, Katan MB, Zock PL. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. American Journal of Clinical Nutrition 2004; 80: 1167–1174
   PubMed Web of Science ®Google Scholar
• Haag M. Essential fatty acids and the brain. Canadian Journal of Psychiatry 2003; 48: 195–203
   PubMed Web of Science ®Google Scholar
• Hallahan B, Garland MR. Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins Leukotrienes and Essential Fatty Acids 2004; 71: 211–216
   PubMedGoogle Scholar
• Hamazaki T, Hirayama S. The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study. European Journal of Clinical Nutrition 2004; 58: 838
   PubMed Web of Science ®Google Scholar
• Hamazaki T, Sawazaki S, Itomura M, Asaoka E, Nagao Y, Nishimura N, et al. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. Journal of Clinical Investigations 1996; 97: 1129–1133
   PubMed Web of Science ®Google Scholar
• Harbige LS. Fatty acids, the immune response, and autoimmunity: A question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003; 38: 323–341
   PubMed Web of Science ®Google Scholar
• Haubner LY, Stockard JE, Saste MD, Benford VJ, Phelps CP, Chen LT, et al. Maternal dietary docosahexanoic acid content affects the rat pup auditory system. Brain Research Bulletin 2002; 58: 1–5
   PubMed Web of Science ®Google Scholar
• Hellgren L, Gillberg IC, Bagenholm A, Gillberg C. Children with deficits in attention, motor control and perception (DAMP) almost grown up: Psychiatric and personality disorders at age 16 years. Journal of Child Psychology and Psychiatry and Allied Disciplines 1994; 35(7)1255–1271
   PubMed Web of Science ®Google Scholar
• Hibbeln JR, Makino KK, Martin CE, Dickerson F, Boronow J, Fenton WS. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biological Psychiatry 2003; 53: 431–441
   PubMedGoogle Scholar
• Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder—a placebo-controlled double-blind study. European Journal of Clinical Nutrition 2004; 58: 467–473
   PubMed Web of Science ®Google Scholar
• Hirshfeld-Becker DR, Biederman J, Faraone SV, Violette H, Wrightsman J, Rosenbaum JF. Temperamental correlates of disruptive behavior disorders in young children: Preliminary findings. Biological Psychiatry 2002; 51: 563–574
   PubMed Web of Science ®Google Scholar
• Holman RT. The slow discovery of the importance of omega 3 essential fatty acids in human health. Journal of Nutrition 1998; 128(2 Suppl)427S–433S
   PubMed Web of Science ®Google Scholar
• Iribarren C, Markovitz JH, Jacobs Jr DR, Schreiner PJ, Daviglus M, Hibbeln JR. Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults—the CARDIA study. European Journal of Clinical Nutrition 2004; 58: 24–31
   PubMed Web of Science ®Google Scholar
• Javitt DC, Shelley AM, Silipo G, Lieberman JA. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. Archives in General Psychiatry 2000; 57: 1131–1137
   PubMedGoogle Scholar
• Jyonouchi H, Sun S, Le H. Pro-inflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology 2001; 120: 170–179
   PubMed Web of Science ®Google Scholar
• Kadesjo B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. Journal of Child Psychology and Psychiatry and Allied Disciplines 2001; 42: 487–492
   PubMed Web of Science ®Google Scholar
• Kaempf Rotzoll DE, Hellstern G, Linderkamp O. Influence of long-chain polyunsaturated fatty acid formula feeds on vitamin E status in preterm infants. International Journal for Vitamin and Nutrition Research 2003; 73: 377–387
   PubMedGoogle Scholar
• Kang JX. The importance of omega-6/omega-3 fatty acid ratio in cell function: The gene transfer of omega-3 fatty acid desaturase. World Reviews of Nutrition & Diet 2003; 92: 23–36
   PubMedGoogle Scholar
• Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychological Medicine 2005; 35: 817–827
   PubMed Web of Science ®Google Scholar
• Levant B, Radel JD, Carlson SE. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behaviour & Brain Research 2004; 152: 49–57
   PubMed Web of Science ®Google Scholar
• Litman BJ, Niu SL, Polozova A, Mitchell DC. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: Visual transduction. Journal of Molecular Neuroscience 2001; 16(2–3)237–242, discussion 279–284
   PubMedGoogle Scholar
• MacDonell LE, Skinner FK, Ward PE, Glen AI, Glen AC, Macdonald DJ, et al. Increased levels of cytosolic phospholipase A2 in dyslexics. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63(1–2)37–39
   PubMedGoogle Scholar
• Marangell LB, Martinez JM, Zboyan HA, Kertz B, Kim HF, Puryear LJ. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. American Journal of Psychiatry 2003; 160: 996–998
   PubMed Web of Science ®Google Scholar
• Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clinical Pediatrics Philadelphia 1987; 26: 406–411
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. NIH Consensus Statement: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (ADHD). National Institutes of Health, Bethesda 1998
   Google Scholar
• Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry 2002; 159(3)477–479
   PubMed Web of Science ®Google Scholar
• Owens JA. The ADHD and sleep conundrum: A review. Journal of Developmental and Behavioral Pediatrics 2005; 26: 312–322
   PubMed Web of Science ®Google Scholar
• Pawlosky RJ, Hibbeln JR, Novotny JA, Salem Jr N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. Journal of Lipid Research 2001; 42(8)1257–1265
   PubMed Web of Science ®Google Scholar
• Peet M, Horrobin DF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry 2002; 59: 913–919
   PubMed Web of Science ®Google Scholar
• Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 2005; 65: 1051–1059
   PubMed Web of Science ®Google Scholar
• Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophrenia Research 2001; 49: 243–251
   PubMed Web of Science ®Google Scholar
• Peet M, Glen I, Horrobin DF. Phospholipid spectrum disorders in psychiatry and neurology. Marius Press, Carnforth 2003
   Google Scholar
• Peet M, Horrobin DF, E-E-Multicentre-Study-Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. Journal of Psychiatry Research 2002; 36(1)7–18
   PubMedGoogle Scholar
• Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1989; 28: 882–887
   PubMed Web of Science ®Google Scholar
• Puri BK, Richardson AJ. The effects of olive oil on omega-3 fatty acids and mood disorders. Archives of General Psychiatry 2000; 57: 715
   PubMedGoogle Scholar
• Puri BK, Leavitt BR, Hayden MR, Ross CA, Rosenblatt A, Greenamyre JT, et al. Ethyl-EPA in Huntington disease: A double-blind, randomized, placebo-controlled trial. Neurology 2005; 65: 286–292
   PubMed Web of Science ®Google Scholar
• Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. Journal of the American Academy of Child and Adolescent Psychiatry 2000; 39(11)1424–1431
   PubMed Web of Science ®Google Scholar
• Richardson AJ. Clinical trials of fatty acid supplementation in dyslexia and dyspraxia. Phospholipid spectrum disorders in psychiatry and neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003; 491–500
   Google Scholar
• Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukotrienes and Essential Fatty Acids 2004a; 70: 383–390
   PubMed Web of Science ®Google Scholar
• Richardson AJ. Long-chain polyunsaturated fatty acids in childhood developmental and psychiatric disorders. Lipids 2004b; 39: 1215–1222
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Montgomery P. The Oxford-Durham study: A randomised controlled trial of fatty acid supplementation in children with developmental coordination disorder. Pediatrics 2005; 115: 1360–1366
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Puri BK. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63: 79–87
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Progress in Neuropsychopharmacology and Biological Psychiatry 2002; 26: 233–239
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopmental disorder: A new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63: 1–9
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Calvin CM, Clisby C, Schoenheimer DR, Montgomery P, Hall JA, et al. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63: 69–74
   PubMed Web of Science ®Google Scholar
• Richardson AJ, Cyhlarova E, Puri BK. Clinical and biochemical fatty acid abnormalities in dyslexia, dyspraxia, and schizotypy: An overview. Phospholipid spectrum disorders in psychiatry and neurology, M Peet, I Glen, DF Horrobin. Marius Press, Carnforth 2003; 477–490
   Google Scholar
• Ross MA, Cyhlarova E, Shrier A, Henderson RJ, MacKinlay EE, Dick JR, et al. Working memory and schizotypal traits in relation to fatty acid status in dyslexia. BrightonUK 2004, ISSFAL 6th International Congress, 2004
   Google Scholar
• Rudin DO. The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: Substrate pellagra. Biological Psychiatry 1981; 16: 837–850
   PubMed Web of Science ®Google Scholar
• Rutter M, Caspi A, Fergusson D, Horwood LJ, Goodman R, Maughan B, et al. Sex differences in developmental reading disability: New findings from four epidemiological studies. Journal of the American Medical Association 2004; 291: 2007–2012
   PubMed Web of Science ®Google Scholar
• Salem Jr N, Pawlosky R, Wegher B, Hibbeln J. In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukotrienes & Essential Fatty Acids 1999; 60(5–6)407–410
   PubMedGoogle Scholar
• Secnik K, Swensen A, Lage MJ. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmaco Economics 2005; 23: 93–102
   PubMed Web of Science ®Google Scholar
• Silvers KM, Woolley CC, Hamilton FC, Watts PM, Watson RA. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukotrienes & Essential Fatty Acids 2005; 72: 211–218
   PubMed Web of Science ®Google Scholar
• Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedical Pharmacotherapy 2002; 56: 365–379
   PubMed Web of Science ®Google Scholar
• Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. Journal of Paediatrics and Child Health 2005; 41: 23–26
   PubMed Web of Science ®Google Scholar
• Stein J, Richardson A. Cognitive disorders: A question of misattribution. Current Biology 1999; 9: R374–376
   Google Scholar
• Stevens L, Zhang W, Peck L, Kuczek T, Grevstat N, Mahon A, et al. EFA supplementation in children with inattention, hyperactivity and other disruptive behaviours. Lipids 2003; 38: 1007–1021
   PubMed Web of Science ®Google Scholar
• Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiology and Behaviour 1996; 59: 915–920
   PubMed Web of Science ®Google Scholar
• Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. American Journal of Clinical Nutrition 1995; 62: 761–768
   PubMed Web of Science ®Google Scholar
• Stoll AL, Freeman MP, Severus WE, Rueter S, Zboyan HA, Diamond E, et al. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial. Archives of General Psychiatry 1999; 56: 407–412
   PubMed Web of Science ®Google Scholar
• Stordy BJ. Benefit of docosahexaenoic acid supplements to dark adaptation in dyslexics. Lancet 1995; 346: 385
   PubMedGoogle Scholar
• Stordy BJ. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. American Journal of Clinical Nutrition 2000; 71: 323S–326S
   PubMed Web of Science ®Google Scholar
• Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology 2003; 13(4)267–271
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Fukumoto Y, Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behavioural Brain Research 2002; 131: 193–203
   PubMed Web of Science ®Google Scholar
• Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M. Which boys respond to stimulant medication% A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine 1987; 17: 121–143
   PubMed Web of Science ®Google Scholar
• Taylor KE, Richardson AJ. Visual function, fatty acids and dyslexia. Prostaglandins Leukotrienes & Essential Fatty Acids 2000; 63: 89–93
   PubMed Web of Science ®Google Scholar
• Taylor KE, Higgins CJ, Calvin CM, Hall JA, Easton T, McDaid AM, et al. Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukotrienes and Essential Fatty Acids 2000; 63: 75–78
   PubMedGoogle Scholar
• Taylor KE, Richardson AJ, Stein JF. Could platelet activating factor play a role in developmental dyslexia%. Prostaglandins Leukotrienes and Essential Fatty Acids 2001; 64: 173–180
   PubMedGoogle Scholar
• Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development. Lipids 2001; 36(9)885–895
   PubMedGoogle Scholar
• Unay B, Sarici SU, Ulas UH, Akin R, Alpay F, Gokcay E. Nutritional effects on auditory brainstem maturation in healthy term infants. Archives of disease in childhood. Fetal and neonatal edition 2004; 89: F177–F179
   PubMedGoogle Scholar
• Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukotrienes and Essential Fatty Acids 2001; 65(1)1–7
   PubMed Web of Science ®Google Scholar
• Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology 2005; 57: 67–81
   PubMed Web of Science ®Google Scholar
• Vincent A, Deacon R, Dalton P, Salmond C, Blamire AM, Pendlebury S, et al. Maternal antibody-mediated dyslexia% Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy. Journal of Neuroimmunology 2002; 130: 243–247
   PubMedGoogle Scholar
• Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. Journal of Pediatrics 2001; 139: 189–196
   PubMed Web of Science ®Google Scholar
• Willcutt EG, Pennington BF. Psychiatric comorbidity in children and adolescents with reading disability. Journal of Child Psychology and Psychiatry and Allied Disciplines 2000; 41(8)1039–1048
   PubMed Web of Science ®Google Scholar
• Willcutt EG, Pennington BF, DeFries JC. Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. American Journal of Medical Genetics 2000; 96(3)293–301
   PubMedGoogle Scholar
• Wolraich ML, Hannah JN, Baumgaertel A, Feurer ID. Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. Journal of Developmental and Behavioural Pediatrics 1998; 19(3)162–168
   PubMed Web of Science ®Google Scholar
• Wolraich ML, Lambert EW, Bickman L, Simmons T, Doffing MA, Worley KA. Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics 2004; 25: 41–47
   PubMed Web of Science ®Google Scholar
• Yao JK, van Kammen DP. Membrane phospholipids and cytokine interaction in schizophrenia. International Review of Neurobiology 2004; 59: 297–326
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy RD, van Kammen DP. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. Central Nervous System Drugs 2001; 15: 287–310
   Google Scholar
• Yehuda S. Omega-6/omega-3 ratio and brain-related functions. World Review of Nutrition and Dietetics 2003; 92: 37–56
   PubMedGoogle Scholar
• Young GS, Conquer JA, Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reproduction Nutrition and Development 2005; 45: 549–558
   PubMedGoogle Scholar
• Young GS, Maharaj NJ, Conquer JA. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder. Lipids 2004; 39: 117–123
   PubMed Web of Science ®Google Scholar
• Zanarini MC, Frankenburg FR. Omega-3 Fatty acid treatment of women with borderline personality disorder: A double-blind, placebo-controlled pilot study. American Journal of Psychiatry 2003; 160: 167–169
   PubMed Web of Science ®Google Scholar
• Zimmer L, Vancassel S, Cantagrel S, Breton P, Delamanche S, Guilloteau D, et al. The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids. American Journal of Clinical Nutrition 2002; 75: 662–667
   PubMed Web of Science ®Google Scholar